AGP Picks
View all

Fresh internet news from the world

Provided by AGP

Today on the Internet: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.

Press releases published on May 12, 2026

Great Plains Communications Named Best TV, Internet and Phone Provider  by Daily News Readers
AriseAlpha Introduces Free AI Trading Bots Accelerate Growth of Automated Crypto Investing (2026)
AITradeBTC Introduces Beginner-Friendly AI Trading Bot to Simplify Automated Investing in 2026
NEVGOLD ANNOUNCES CLOSING OF UPSIZED $42M BROKERED PRIVATE PLACEMENT FINANCING
Saviynt Strengthens Executive Team to Accelerate AI Identity Security Leadership
99% of High Point University Graduates Continue to Be Employed or Furthering Their Education Within 180 Days of Graduation
Vereigen Media Announces 'London Marketers Connect' An Exclusive B2B Marketing Gathering on the Thames, June 2026
Airia Named Top Platform in Legal AI at Theorem's Spring 2026 LegalTech Awards
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress
Picogrid Joins U.S. Army’s “Right to Integrate” Sprint at Fort Carson to Accelerate Vendor-Neutral Interoperability
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting
BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress
Alpha Compute Closes $32.2 Million Revenue Contract with AI Lab Customer
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Share us

on your social networks:

Sign up for:

Today on the Internet

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.